在查加斯病的宿主-T. cruzi-环境相互作用的小分子媒介
Godwin Kwakye-Nuako1,2, Caitlyn E Middleton3, Laura-Isobel McCall1,3
1Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma, United States of America.
PLoS pathogens
|March 8, 2024
概括
小分子调节宿主-病原体-微生物群相互作用. 针对由Trypanosoma cruzi引起的查加斯病的代谢变化提供了新的治疗策略.
科学领域:
- 生物化学和分子生物学
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
背景情况:
- 小分子 (<1500 Da) 对于宿主-病原体-微生物群通信和细胞过程至关重要.
- 病原体代谢和宿主免疫反应影响感染动态和疾病进展.
- 由Trypanosoma cruzi引起的查加斯病是一种被忽视的热带疾病,具有显著的心脏和肠道并发症.
研究的目的:
- 为了阐明小分子在Trypanosoma cruzi感染中的作用,在载体和哺乳动物宿主中.
- 开发一个理论框架,解释代谢失调如何驱动查加斯病的病原性.
- 基于代谢干预,确定沙加斯病的潜在治疗点.
主要方法:
- 审查和整合关于小分子,宿主-病原体相互作用和查加斯病的现有文献.
- 对Trypanosoma cruzi及其宿主相关的代谢途径的分析.
- 在感染期间代谢变化的理论建模.
主要成果:
- 小分子介导Trypanosoma cruzi,宿主和微生物组之间的关键信号传递和代谢交换.
- 受免疫信号和微生物代谢物影响的宿主代谢变化,有助于查加斯病的病理学.
- 特定的Trypanosoma cruzi的代谢脆弱性和宿主代谢失调被确定为潜在的治疗点.
结论:
- 了解小分子动力学是破译查加斯病病因的关键.
- 针对病原体代谢和宿主代谢适应不良,为新药开发提供了一个有前途的途径.
- 这种综合方法为开发有效的治疗Trypanosoma cruzi感染提供了基础.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


